Plasma metabolomics profiling identifies new predictive biomarkers for disease severity in COVID-19 patients
Description
Recently, numerous studies have reported on different predictive models of disease severity in COVID-19 patients. Herein, we propose a highly predictive model of disease severity by integrating routine laboratory findings and plasma metabolites
